ATE82122T1 - Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l- lysin. - Google Patents
Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l- lysin.Info
- Publication number
- ATE82122T1 ATE82122T1 AT89402257T AT89402257T ATE82122T1 AT E82122 T1 ATE82122 T1 AT E82122T1 AT 89402257 T AT89402257 T AT 89402257T AT 89402257 T AT89402257 T AT 89402257T AT E82122 T1 ATE82122 T1 AT E82122T1
- Authority
- AT
- Austria
- Prior art keywords
- carnitine
- lysine
- pharmaceutical
- compositions containing
- dietetic compositions
- Prior art date
Links
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 title abstract 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract 2
- 235000005911 diet Nutrition 0.000 title abstract 2
- 230000000378 dietary effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 206010018429 Glucose tolerance impaired Diseases 0.000 abstract 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 abstract 1
- 206010019663 Hepatic failure Diseases 0.000 abstract 1
- 235000019766 L-Lysine Nutrition 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- -1 inorganic acid salts Chemical class 0.000 abstract 1
- 230000003387 muscular Effects 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8810886A FR2635264B1 (fr) | 1988-08-12 | 1988-08-12 | Compositions pharmaceutiques et/ou dietetiques contenant de la l-carnitine et de la l-lysine |
| EP89402257A EP0354848B1 (fr) | 1988-08-12 | 1989-08-10 | Compositions pharmaceutiques et/ou diététiques contenant de la L-carnitine et de la L-lysine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE82122T1 true ATE82122T1 (de) | 1992-11-15 |
Family
ID=9369324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89402257T ATE82122T1 (de) | 1988-08-12 | 1989-08-10 | Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l- lysin. |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP0354848B1 (https=) |
| JP (1) | JP2785989B2 (https=) |
| AT (1) | ATE82122T1 (https=) |
| CA (1) | CA1341260C (https=) |
| DE (2) | DE68903448T2 (https=) |
| ES (1) | ES2043062T3 (https=) |
| FR (1) | FR2635264B1 (https=) |
| GR (2) | GR900300149T1 (https=) |
| PT (1) | PT91430B (https=) |
| WO (1) | WO1990001316A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2660557B1 (fr) * | 1990-04-09 | 1994-05-27 | Endobio Groupe Etu Rech Risqu | Compositions pharmaceutiques et/ou dietetiques contenant de la carnitine, de la lysine et de la methionine avec ou sans acide pantothenique. |
| US6080788A (en) * | 1997-03-27 | 2000-06-27 | Sole; Michael J. | Composition for improvement of cellular nutrition and mitochondrial energetics |
| IT1306147B1 (it) * | 1999-05-28 | 2001-05-30 | Biosalts Srl | Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali |
| IT1306186B1 (it) | 1999-09-03 | 2001-05-30 | Biosalts Srl | Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale |
| IT1317042B1 (it) | 2000-06-14 | 2003-05-26 | Biosalts Srl | Fumarati doppi di una carnitina e creatina, e integratori alimentari,dietetici e farmaci che li contengono. |
| JP6766044B2 (ja) * | 2015-07-01 | 2020-10-07 | 株式会社明治 | 継粉形成抑制剤 |
| AU2018258250A1 (en) | 2017-04-25 | 2019-12-12 | Almeda Labs Llc | Amino acid formulations for pancreatic viability |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR4465M (https=) * | 1965-06-28 | 1966-09-26 | ||
| FR2119882A1 (en) * | 1970-12-31 | 1972-08-11 | Prugnaud Robert | Calcium hypophosphite-ascorbate/carnitine compsn - used as appetite stimulant |
| US3830931A (en) * | 1972-11-06 | 1974-08-20 | Felice S De | Carnitine and its use in the treatment of arrhythmia and impaired cardiac function |
| US3968241A (en) * | 1972-11-06 | 1976-07-06 | Defelice Stephen L | Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof |
| IT1120033B (it) * | 1979-10-05 | 1986-03-19 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale |
| DE3026368A1 (de) * | 1980-07-11 | 1982-02-18 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion |
-
1988
- 1988-08-12 FR FR8810886A patent/FR2635264B1/fr not_active Expired - Fee Related
-
1989
- 1989-08-01 CA CA000607172A patent/CA1341260C/fr not_active Expired - Fee Related
- 1989-08-10 PT PT91430A patent/PT91430B/pt not_active IP Right Cessation
- 1989-08-10 AT AT89402257T patent/ATE82122T1/de not_active IP Right Cessation
- 1989-08-10 EP EP89402257A patent/EP0354848B1/fr not_active Expired - Lifetime
- 1989-08-10 WO PCT/FR1989/000419 patent/WO1990001316A1/fr not_active Ceased
- 1989-08-10 ES ES89402257T patent/ES2043062T3/es not_active Expired - Lifetime
- 1989-08-10 DE DE8989402257T patent/DE68903448T2/de not_active Expired - Fee Related
- 1989-08-10 JP JP1508982A patent/JP2785989B2/ja not_active Expired - Lifetime
- 1989-08-10 DE DE198989402257T patent/DE354848T1/de active Pending
- 1989-08-10 EP EP89909580A patent/EP0428608A1/fr active Pending
-
1991
- 1991-09-27 GR GR90300149T patent/GR900300149T1/el unknown
-
1992
- 1992-12-21 GR GR920403006T patent/GR3006598T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE68903448D1 (de) | 1992-12-17 |
| CA1341260C (fr) | 2001-06-19 |
| GR900300149T1 (en) | 1991-09-27 |
| DE68903448T2 (de) | 1993-03-18 |
| DE354848T1 (de) | 1992-05-21 |
| JP2785989B2 (ja) | 1998-08-13 |
| PT91430B (pt) | 1995-05-31 |
| FR2635264B1 (fr) | 1992-02-28 |
| WO1990001316A1 (fr) | 1990-02-22 |
| GR3006598T3 (https=) | 1993-06-30 |
| PT91430A (pt) | 1990-03-08 |
| ES2043062T3 (es) | 1993-12-16 |
| FR2635264A1 (fr) | 1990-02-16 |
| EP0428608A1 (fr) | 1991-05-29 |
| EP0354848B1 (fr) | 1992-11-11 |
| JPH04500073A (ja) | 1992-01-09 |
| EP0354848A1 (fr) | 1990-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5091171B1 (en) | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | |
| DE69629273D1 (de) | Zusammensetzungen enthaltend Propionyl-L-Carnitine und Hydroxyzitronensäure oder Pantothensäure | |
| PT614616E (pt) | Composicao para o tratamento de pacientes com doenca hepatica | |
| ATE129894T1 (de) | Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen. | |
| NO306655B1 (no) | Anvendelse av GLA, DGLA eller LA ved fremstilling av et medisinsk preparat | |
| DK341187D0 (da) | Virucidt middel med bredspekret virkning | |
| IT1291113B1 (it) | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito | |
| NO893239D0 (no) | Farmasoeytisk preparat for behandling av diabetes mellitus. | |
| ATE65397T1 (de) | Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol. | |
| PT1216041E (pt) | Dieta com elevado teor de lipidos | |
| ES8106513A1 (es) | Procedimiento para la preparacion de sales de la (+)-cate- quina | |
| BR9401199A (pt) | Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento. | |
| ATE82122T1 (de) | Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l- lysin. | |
| ES2134320T3 (es) | Composicion a base de retinoides. | |
| KR910000158A (ko) | 의약용 화합물 및 그것의 사용방법 | |
| ATE22804T1 (de) | Pharmazeutische zusammensetzung. | |
| PT95212A (pt) | Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide | |
| FI934082A0 (fi) | Kitosanbaserade naerings- och laekemedelskompositioner foer idisslare | |
| ATE34662T1 (de) | Derivate der benzoesaeure, herstellungsverfahren und anwendung in desinfizierenden und konservierenden arzneimitteln. | |
| SE8902607D0 (sv) | Oxaza heterocycles and pharmaceutical compositions containing same | |
| ATE79750T1 (de) | Pharmazeutische zusammensetzung mit antikrebswirkung und methode fuer die behandlung von krebs. | |
| ES2126015T3 (es) | Uso de etofibrato y composiciones farmaceuticas que contienen etofibrato para el tratamiento de la angiopatia y la retinopatia diabeticas. | |
| KR900015616A (ko) | 배나무 점무늬병 치료제. | |
| GT198500020A (es) | 1,4-dihidropiridinlactonas 1-alquil-sustituidas, procedimiento para su obtencion y su empleo en medicamentos. | |
| MacLaren | An in vitro comparison of stress resistance of five bonding products under a moisture stress environment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |